BRIEF published on 06/24/2024 at 18:52, 4 months 28 days ago Funding Circle Plc: POS-Transaction in Own Shares London Stock Exchange Shares Regulations Funding Circle Buy-back
PRESS RELEASE published on 06/24/2024 at 18:47, 4 months 28 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces the purchase and cancellation of 52,649 of its ordinary shares on the London Stock Exchange from Numis Securities Limited as part of its buy-back program London Stock Exchange Ordinary Shares Purchase Cancellation Funding Circle Plc
BRIEF published on 06/21/2024 at 18:26, 5 months 1 day ago Funding Circle Plc Announces Share Buy-Back Transaction Share Buy-back London Stock Exchange Ordinary Shares Funding Circle Deutsche Numis
PRESS RELEASE published on 06/21/2024 at 18:21, 5 months 1 day ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Holdings plc announced the purchase of 100,000 of its ordinary shares for cancellation at prices ranging from 83.80p to 85.40p per share on the London Stock Exchange London Stock Exchange Ordinary Shares Share Buyback Cancellation Funding Circle Plc
BRIEF published on 06/20/2024 at 17:52, 5 months 2 days ago Funding Circle Plc Purchases Own Shares for Cancellation Share Buy-back London Stock Exchange Funding Circle Issued Share Capital
PRESS RELEASE published on 06/20/2024 at 17:47, 5 months 2 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces purchase and cancellation of 150,000 ordinary shares on the London Stock Exchange. Share capital to consist of 350,000,159 shares post-cancellation Share Capital London Stock Exchange Share Purchase Cancellation Funding Circle Plc
BRIEF published on 06/19/2024 at 18:31, 5 months 3 days ago Funding Circle Plc: POS-Transaction in Own Shares London Stock Exchange Ordinary Shares Funding Circle Buy-back
PRESS RELEASE published on 06/19/2024 at 18:26, 5 months 3 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Holdings plc announces purchase and cancellation of 133,637 ordinary shares. Shares were acquired from Numis Securities Limited on 19 June 2024 at prices ranging from 82.40p to 85.00p London Stock Exchange Share Buyback Numis Securities Limited Funding Circle Plc Share Cancellation
BRIEF published on 06/19/2024 at 10:04, 5 months 3 days ago Funding Circle PDMRs Acquire Shares under Incentive Plan Share Incentive Plan Funding Circle Lisa Jacobs Employee Shares Oliver White
PRESS RELEASE published on 06/19/2024 at 09:59, 5 months 3 days ago Funding Circle Plc: Funding Circle Plc announces PDMRs acquiring Partnership Shares and Matching Shares under the Share Incentive Plan on 17 June 2024 Acquisition Share Incentive Plan Funding Circle Plc Matching Shares PDMRs
Published on 11/22/2024 at 23:55, 48 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 hour 13 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 hour 38 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 2 hours 13 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 6 hours 29 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 6 hours 50 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 7 hours 48 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 8 hours 43 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 1 day 17 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 5 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 6 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 6 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024